Home > Financial Ratios > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
EBIT Growth

    Back to All Ratios
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for EMCURE PHARMACEUTICALS
Please provide your vote to see the results

EMCURE PHARMACEUTICALS Last 5 Year EBIT Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EBIT Growth(%) 0.37-16.3434.26136.36-34.58

What is the latest EBIT Growth ratio of EMCURE PHARMACEUTICALS ?

The latest EBIT Growth ratio of EMCURE PHARMACEUTICALS is 0.37 based on Mar2024 Consolidated results.
Year EBIT Growth
Mar20240.37
Mar2023-16.34
Mar202234.26
Mar2021136.36
Mar2020-34.58

How is EBIT Growth of EMCURE PHARMACEUTICALS Trending?

Years EBIT Growth % Change
Mar2024 0.37
Positive
Mar2023 -16.34
Negative
Mar2022 34.26
-74.88
Mar2021 136.36
Positive
Mar2020 -34.58 -

Other Financial Ratios of EMCURE PHARMACEUTICALS


Compare EBIT Growth ratio of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹20,743.6 Cr 20.9% 18.2% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹420,136.0 Cr 6% 4% 9.9% Stock Analytics
DIVIS LABORATORIES ₹149,680.0 Cr 4.7% 0.3% 52.4% Stock Analytics
CIPLA ₹122,394.0 Cr 7% 3.7% 7.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,159.0 Cr 4.1% 6.4% 25% Stock Analytics
DR REDDYS LABORATORIES ₹97,105.6 Cr 6.3% 5% -4.7% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

20.9%

18.2%

NA
SENSEX

5.8%

6.1%

4.7%


You may also like the below Video Courses